ID   409B2
AC   CVCL_K092
SY   409-B2; 409B-2; HPS0076; BRCi023-A
DR   BioSamples; SAMEA114468321
DR   GEO; GSM1040275
DR   GEO; GSM1040345
DR   GEO; GSM1489195
DR   GEO; GSM1489224
DR   GEO; GSM1489251
DR   GEO; GSM1489428
DR   hPSCreg; BRCi023-A
DR   RCB; HPS0076
DR   SKIP; SKIP000218
DR   Wikidata; Q54602867
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=23434393;
RX   PubMed=24259714;
RX   PubMed=25231866;
RX   PubMed=25665923;
RX   PubMed=26997647;
RX   PubMed=27476965;
RX   PubMed=30127392;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: DNA methylation analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 7,19
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 13
//
RX   PubMed=21460823; DOI=10.1038/nmeth.1591;
RA   Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S.,
RA   Hong H.-J., Nakagawa M., Tanabe K., Tezuka K.-i., Shibata T.,
RA   Kunisada T., Takahashi M., Takahashi J., Saji H., Yamanaka S.;
RT   "A more efficient method to generate integration-free human iPS
RT   cells.";
RL   Nat. Methods 8:409-412(2011).
//
RX   PubMed=22802639; DOI=10.1073/pnas.1209979109;
RA   Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N.,
RA   Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.;
RT   "Donor-dependent variations in hepatic differentiation from
RT   human-induced pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012).
//
RX   PubMed=23434393; DOI=10.1016/j.stem.2013.01.009;
RA   Kondo T., Asai M., Tsukita K., Kutoku Y., Ohsawa Y., Sunada Y.,
RA   Imamura K., Egawa N., Yahata N., Okita K., Takahashi K., Asaka I.,
RA   Aoi T., Watanabe A., Watanabe K., Kadoya C., Nakano R., Watanabe D.,
RA   Maruyama K., Hori O., Hibino S., Choshi T., Nakahata T., Hioki H.,
RA   Kaneko T., Naitoh M., Yoshikawa K., Yamawaki S., Suzuki S., Hata R.,
RA   Ueno S.-i., Seki T., Kobayashi K., Toda T., Murakami K., Irie K.,
RA   Klein W.L., Mori H., Asada T., Takahashi R., Iwata N., Yamanaka S.,
RA   Inoue H.;
RT   "Modeling Alzheimer's disease with iPSCs reveals stress phenotypes
RT   associated with intracellular Abeta and differential drug
RT   responsiveness.";
RL   Cell Stem Cell 12:487-496(2013).
//
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110;
RA   Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H.,
RA   Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N.,
RA   Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J.,
RA   Yamanaka S.;
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).
//
RX   PubMed=25231866; DOI=10.1038/nature13775;
RA   Yamashita A., Morioka M., Kishi H., Kimura T., Yahara Y., Okada M.,
RA   Fujita K., Sawai H., Ikegawa S., Tsumaki N.;
RT   "Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.";
RL   Nature 513:507-511(2014).
//
RX   PubMed=25665923; DOI=10.1016/j.scr.2015.01.007;
RA   Toyoda T., Mae S.-i., Tanaka H., Kondo Y., Funato M., Hosokawa Y.,
RA   Sudo T., Kawaguchi Y., Osafune K.;
RT   "Cell aggregation optimizes the differentiation of human ESCs and
RT   iPSCs into pancreatic bud-like progenitor cells.";
RL   Stem Cell Res. 14:185-197(2015).
//
RX   PubMed=26997647; DOI=10.1016/j.stemcr.2016.02.011;
RA   Ichiyanagi N., Fujimori K., Yano M., Ishihara-Fujisaki C., Sone T.,
RA   Akiyama T., Okada Y., Akamatsu W., Matsumoto T., Ishikawa M.,
RA   Nishimoto Y., Ishihara Y., Sakuma T., Yamamoto T., Tsuiji H.,
RA   Suzuki N., Warita H., Aoki M., Okano H.;
RT   "Establishment of in vitro FUS-associated familial amyotrophic lateral
RT   sclerosis model using human induced pluripotent stem cells.";
RL   Stem Cell Reports 6:496-510(2016).
//
RX   PubMed=27476965; DOI=10.1016/j.stem.2016.06.019;
RA   Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M.,
RA   Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M.,
RA   Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A.,
RA   Yamanaka S., Yoshida Y.;
RT   "Epigenetic variation between human induced pluripotent stem cell
RT   lines is an indicator of differentiation capacity.";
RL   Cell Stem Cell 19:341-354(2016).
//
RX   PubMed=30127392; DOI=10.1038/s41591-018-0140-5;
RA   Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R.,
RA   Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., Okano H.;
RT   "Modeling sporadic ALS in iPSC-derived motor neurons identifies a
RT   potential therapeutic agent.";
RL   Nat. Med. 24:1579-1589(2018).
//